Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The intracellular localization of soluble and membrane-bound isoforms of rat and human
catechol O-methyltransferase
(
COMT
) was studied by expressing the recombinant
COMT
proteins either separately or together in mammalian cell lines (HeLa and COS-7 cells) and in rat primary neurons. The distribution of soluble and membrane-bound
COMT
enzyme was visualized by immunocytochemistry. For comparison, the localization of native
COMT
was studied in rat C6
glioma
cells by immunoelectron microscopy. Staining of cells expressing membrane-bound
COMT
with a
COMT
-specific antiserum revealed an immunofluorescence signal in intracellular reticular structures and in the nuclear membrane. Double-staining of the cells with antisera against proteins specific for the rough endoplasmic reticulum indicated that they colocalized with membrane-bound
COMT
, suggesting that it resided in the endoplasmic reticulum. Notably, no
COMT
-specific fluorescence of plasma membranes was detected. The signal in the endoplasmic reticulum was also evident in the cells expressing both recombinant
COMT
forms. Intracellular native
COMT
reaction was detected by immunoelectron microscopy in rat C6
glioma
cells and an intense cytoplasmic signal was seen in the primary neurons infected with the recombinant Semliki Forest virus. The cells expressing recombinant soluble
COMT
revealed intense nuclear staining together with diffuse cytoplasmic immunoreactivity, suggesting that a part of soluble
COMT
is transported to nuclei. Western blotting from rat liver and brain revealed soluble
COMT
in the nuclei. Enzyme activity measurements from liver cytoplasmic and nuclear fractions suggested that about 5% of the soluble
COMT
resided in nuclei. The intracellular localization of both
COMT
forms implies that
COMT
acts in the cytoplasm and possibly also in the nuclear compartment, and that the physiological substrates of
COMT
enzymes may have to be internalized before their methylation by
COMT
.
...
PMID:Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. 903 Jul 72
The kinetic parameters of monoamine oxidase (MAO; E.C 1.4.3.4) and catechol-O-methyltransferase (COMT;
EC 2.1.1.6
) were evaluated in extracts of adrenergic and non-adrenergic mouse neuroblastoma cells and in rat
glioma
cells. Using the naturally-occurring substrates tyramine, tryptamine, serotonin and norepinephrine, the affinity of MAO for a given substrate was independent of the presence of the catecholaminergic pathway or cell type used, with apparent Km values ranging from 8-14 microM for tryptamine to 510-580 microM for norepinephrine. The MAO activity in
glioma
cells was substantially greater than in either neuroblastoma clone, but Vmax values varied little with substrate among cell lines. Both the neuronal and glial COMT had a similar Km for 1-norepinephrine (200 microM); the corresponding Vmax values were also similar among the different cell lines, but represented only 2-10% of the maximal MAO activity. Neuroblastoma and
glioma
cells, when grown from early logarithmic to stationary phase, showed no significant changes in specific activity of either MAO or COMT. Growth of cells for 3 days with 1 mM-N6,O2'-dibutyryl adenosine-3',5'-cyclic monophosphate resulted in no marked change in either MAO or COMT activity. These results suggest that in neurons neither MAO nor COMT plays a major role in the type of transmitter inactivation that is analogous to that of acetylcholinesterase in cholinergic synapses. The occurrence of considerable MAO and acetylcholinesterase activities in
glioma
cells may indicate a role for these cells in neurotransmitter inactivation.
...
PMID:Metabolism of biogenic amines in neuroblastoma and glioma cells in culture. 1217 May 89